Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Pharmaceuticals:

Photonics Spectra
Aug 1997
Photonics Prevents Recalls

Herbert Kaplan

The 1990s have marked a decade of significant change for quality control in the pharmaceutical industry. New governmental regulations in the US have prompted capital expenditures for automated inspection equipment that is increasingly replacing human inspectors -- and doing so more accurately.
In 1992, the average pharmaceutical recall cost $1.5 million for lost sales, production, disposal and notification. A year later, the FDA published new regulations about labeling and inspection. The regulations allowed continued use of human inspectors, but they indicated a strong preference for automated inspection, such as machine vision systems.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x Subscribe to Photonics Spectra magazine - FREE!